Arteriovenous Malformations Market Report 2026

Arteriovenous Malformations Market Overview

• Arteriovenous Malformations market size has reached to $3.1 billion in 2025 • Expected to grow to $4.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Rising Demand For Minimally Invasive Procedures Fueling The Growth Of The Market Due To Faster Recovery And Reduced Complications • Market Trend: Advancements In Liquid Embolic System Procedural Sets For Neurovascular Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Arteriovenous Malformations Market?

Arteriovenous malformations refer to abnormal tangles of blood vessels that create direct connections between arteries and veins, bypassing the normal capillary system. This disrupts normal blood flow and oxygen circulation, potentially leading to complications. Early diagnosis and appropriate treatment are crucial to managing symptoms and reducing the risk of serious complications. The main types of arteriovenous malformations are true arteriovenous malformation, occult or cryptic, cavernous malformations, venous malformation, hemangioma, dural fistula, others. True arteriovenous malformation refers to a congenital vascular anomaly characterized by a direct connection between arteries and veins, bypassing the capillary system. The various diagnosis includes physical examination, brain scans, others. The various treatment includes endovascular embolization, neurosurgery with various age group such as adult patients, pediatric patients. These are also used by various end-users such as hospitals and clinics, research laboratories, others.

What Is The Arteriovenous Malformations Market Growth Forecast?

The arteriovenous malformations market size is expected to see strong growth in the next few years. It will grow to $4.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, rising investments in neurovascular research, expansion of minimally invasive treatment adoption, growing focus on personalized treatment planning, increasing availability of advanced interventional devices. Major trends in the forecast period include increasing adoption of advanced neuroimaging diagnostics, rising use of minimally invasive endovascular treatments, growing focus on early and accurate diagnosis, expansion of multidisciplinary treatment approaches, enhanced monitoring of post-treatment outcomes.

Global Arteriovenous Malformations Market Segmentation

1) By Type: True Arteriovenous Malformation, Occult Or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Other Types 2) By Diagnosis: Physical examination, Brain Scans, Other Diagnosis 3) By Treatment: Endovascular Embolization, Neurosurgery 4) By Age Group: Adult Patients, Pediatric Patients 5) By End-User: Hospitals And Clinics, Research laboratories, Other End-Users Subsegments: 1) By True Arteriovenous Malformation: Pial AVMs, Spinal AVMs, Brain AVMs, Extremity AVMs, Visceral AVMs 2) By Occult or Cryptic: Micro-AVMs, Hidden AVMs, Asymptomatic AVMs, Deep-Seated AVMs, Small-Scale AVMs 3) By Cavernous Malformations: Cerebral Cavernous Malformations (CCMs), Spinal Cavernous Malformations, Familial Cavernous Malformations, Solitary Cavernous Malformations, Multiple Cavernous Malformations 4) By Venous Malformation: Superficial Venous Malformations, Deep Venous Malformations, Mixed Venous Malformations, Syndromic Venous Malformations, Blue Rubber Bleb Nevus Syndrome 5) By Hemangioma: Infantile Hemangiomas, Capillary Hemangiomas, Lobular Capillary Hemangiomas, Cavernous Hemangiomas, Compound Hemangiomas 6) By Dural Fistula: Cranial Dural Arteriovenous Fistula (dAVF), Spinal Dural Arteriovenous Fistula, Direct Dural AV Fistula, Indirect Dural AV Fistula, High-Flow Dural Fistula 7) By Other Types: Lymphatic Malformations, Mixed Vascular Malformations, Arteriovenous Aneurysms, Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs, Rare Congenital AVMs

What Are The Drivers Of The Arteriovenous Malformations Market?

The rising demand for minimally invasive procedures is expected to propel the growth of the arteriovenous malformations market going forward. Minimally invasive procedures refer to surgical or therapeutic interventions performed with small incisions or catheter-based techniques to reduce trauma, recovery time, and complications. The rising demand for minimally invasive surgeries is due to faster recovery times, as these procedures involve smaller incisions, causing less trauma to tissues and reducing healing time. This allows patients to return to their daily activities more quickly compared to traditional open surgeries, making it a preferred choice for both patients and healthcare providers. Arteriovenous malformations (AVMs) support minimally invasive procedures by allowing advanced techniques such as endovascular embolization, which uses catheters and image-guided interventions to reduce abnormal blood flow without the need for open surgery, leading to lower risks, shorter recovery times, and improved patient outcomes. For instance, in September 2023, according to the American Society of Plastic Surgeons, a US-based in 2023, a total of 25,442,640 cosmetic minimally invasive procedures were performed, representing an increase from 23,672,269 procedures in 2022. This reflects a 7% growth in minimally invasive treatments for both genders in 2023. Therefore, the rising demand for minimally invasive procedures is driving the growth of the arteriovenous malformations industry. The increasing investment in biotechnology is expected to propel the growth of the arteriovenous malformations market going forward. Biotechnology refers to the use of biological processes, organisms, or systems to develop products and technologies for healthcare. Increasing investments in biotechnology are due to breakthroughs in gene editing technologies such as CRISPR, which enable precise genetic modifications with innovations in medicine. Arteriovenous malformations (AVMs) contribute to biotechnology by enhancing medical imaging, gene therapy, and minimally invasive treatments, resulting in biotechnology-based solutions such as targeted drug delivery, biomaterials for vascular repair, and AI-assisted diagnostics. For instance, in August 2024, according to The BioIndustry Association (BIA), a UK-based trade association for innovative life sciences and the biotech industry, in 2024, the UK's life sciences and biotechnology sector recorded its strongest investment quarter since the pandemic, securing $2.55 billion in the first two quarters of the year and surpassing the $2.32 billion raised in 2023. Therefore, the increasing investment in biotechnology is driving the growth of the arteriovenous malformations industry.

Key Players In The Global Arteriovenous Malformations Market

Major companies operating in the arteriovenous malformations market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Terumo Corporation, Penumbra Inc, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc, Balt LLC, Shape Memory Medical Inc, MicroVention Inc, Cerenovus, Brainlab AG, Boston Scientific Corporation, Abbott Laboratories, B Braun Melsungen AG, Siemens Healthineers AG, GE Healthcare Technologies Inc, Koninklijke Philips NV, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation

Global Arteriovenous Malformations Market Trends and Insights

Major companies operating in the arteriovenous malformations market are focusing on technological advancements, such as liquid embolic system procedural sets, to streamline treatment procedures and improve patient outcomes. The liquid embolic system procedural set refers to a pre-assembled, sterilized kit containing essential components for delivering liquid embolic agents to treat vascular abnormalities like arteriovenous malformations (AVMs). For instance, in March 2024, CERENOVUS Inc., a US-based neurovascular care company under Johnson and Johnson MedTech, launched the TRUFILL n-BCA liquid embolic system procedural set. This new set includes two configurations and the necessary accessories for preparing and delivering the n-BCA liquid embolic system in a single sterilized package, optimizing procedure preparation for treating cerebral arteriovenous malformations (AVMs).

Regional Outlook

North America was the largest region in the arteriovenous malformations market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Arteriovenous Malformations Market?

The arteriovenous malformations market consists of revenues earned by entities by providing services such as minimally invasive embolization, post-procedure rehabilitation, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The arteriovenous malformations market also includes sales of embolization devices, neurovascular catheters, liquid embolic agents, microsurgical instruments, and imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Arteriovenous Malformations Market Report 2026?

The arteriovenous malformations market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the arteriovenous malformations industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.